Subscribe to MDT Magazine News

TSX-listed corporate dividends and distributions declared May 19, 2011

May 19, 2011 10:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on May 19, 2011.Bonavista Energy Corporation (TSX:BNP): $0.12. Payable Jun 15. Record May 31.Enbridge Inc. (TSX:ENB): $0.49. Payable Jun 01. Record May 13.Allied Properties Real...

Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise

May 19, 2011 10:43 am | by Bio-Medicine.Org | Comments

DEERFIELD, Ill., May 19, 2011 /- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Reisenauer will be responsible for all U.S....


Infinity Pharma: One cancer drug advances, one ends development

May 19, 2011 10:42 am | by Mass High Tech: The Journal of New England Technology | Comments

Infinity Pharmaceuticals Inc. is launching a Phase 2 trial of its potential treatment for non-small cell lung cancer, retaspimycin HCl in combination with the approved chemotherapy drug, Taxotere, marketed by French drug maker Sanofi.


Syneron rises on smaller 1Q loss

May 19, 2011 8:45 am | by The Associated Press | Comments

Shares of cosmetic device firm Syneron Medical Ltd. climbed Thursday after the company reported a narrower first quarter loss on double-digit revenue growth.The results beat Wall Street expectations, and Syneron shares rose 80 cents, or 6.5 percent, to $13.09 in midday trading.The Israeli...

OrbusNeich's Genousâ„¢ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011

May 19, 2011 8:42 am | by Bio-Medicine.Org | Comments

PARIS, May 19, 2011 /- OrbusNeich announced that data from multiple clinical trials supporting the safety and efficacy of the Genous Stent in cases where prolonged dual antiplatelet therapy (DAPT) is not advisable were featured today during the HEALING Symposium titled "How to assess and...


Spaulding Clinical Honored at BizTech Conference

May 19, 2011 8:39 am | by Bio-Medicine.Org | Comments

WEST BEND, Wis., May 19, 2011 /- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly receives the 2011 IQ (Innovation Quotient) award sponsored by the Marquette University's Graduate School of Management and BizTimes Media, a magazine...


MEDRAD Launches Second Generation Integoâ„¢ PET Infusion System

May 19, 2011 7:38 am | by Bio-Medicine.Org | Comments

WARRENDALE, Pa., May 19, 2011 /- MEDRAD, INC., a business of Bayer HealthCare, has announced the launch of the next generation Intego™ PET Infusion System, which features a new design that is 38% smaller, power-driven and includes enhancements to technologist workflow.  The new...


Paramaxâ„¢ Moves Closer To FDA Approval

May 19, 2011 7:38 am | by Bio-Medicine.Org | Comments

SALT LAKE CITY, May 19, 2011 /- Paradigm Medical Industries, Inc. (OTC.PK: PDMI) announced today that it had received notification from its Italian partner, Costruzione Strumenti Oftalmici (CSO), which manufactures the Paramax™, that it has provided 26 pages and 24 attachments to...


Enhanced Equity Fund and James White Invest in MedTest DX, Inc.(2)

May 19, 2011 6:36 am | by Bio-Medicine.Org | Comments

NEW YORK, May 19, 2011 /- Enhanced Equity Fund (EEF), a healthcare-focused private equity firm, and executive James White announced their investment in MedTest DX, Inc. (MedTest), a medical diagnostic company based in Cortlandt Manor, NY.  MedTest was created to purchase the...


Public Meeting: Ultra High Throughput Sequencing for Clinical Diagnostic Applications - Approaches to Assess Analytical Validity, June 23, 2011

May 19, 2011 5:48 am | by U.S. Food & Drug Administration | Comments

The purpose of the meeting is to discuss challenges in assessing analytical performance for ultra high throughput genomic sequencing-based clinical applications.

Thermo Fisher Scientific to buy Phadia for $3.5B

May 19, 2011 5:45 am | by The Associated Press | Comments

Scientific instrument maker Thermo Fisher Scientific says it has agreed to pay about $3.5 billion in cash for the Swedish company Phadia, which makes blood test systems for allergy and auto-immune diseases.Thermo Fisher Scientific Inc. expects the deal to be completed in the fourth quarter. It...

Swissray Sells Another DR System to a Large Orthopedic Practice in Florida

May 19, 2011 5:43 am | by Bio-Medicine.Org | Comments

EAST BRUNSWICK, N.J., May 19, 2011 /- Swissray International, Inc., a leading manufacturer of direct digital Radiography ( ddR ) systems, announced today that they have sold another ddR Formula DR system to the Orthopedic Associates of Fort Walton Beach., Florida. For more than a decade...


CardioMEMS Founder & CEO Dr. Jay Yadav Named Ernst & Young Entrepreneur of the Year Finalist

May 19, 2011 5:37 am | by Bio-Medicine.Org | Comments

ATLANTA, May 19, 2011 /- CardioMEMS, Inc ., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, announced today that its founder and CEO, Jay Yadav, M.D. , is a finalist for the...


Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA

May 19, 2011 5:36 am | by Bio-Medicine.Org | Comments

CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S. Food and Drug Administration to commence a Phase I safety study in healthy volunteers for RG3039, formerly called...


The New Era of Crohns Imaging: A Multimodality Approach

May 19, 2011 5:35 am | by Diagnostic Imaging | Comments

New techniques such as magnetic resonance imaging (MRI) imaging of the small bowel and perianal imaging have revolutionized the management of Crohns patients obtaining detailed information of the activity and extent of disease as well complications. CT imaging continues to be used mainly...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.